Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine

BACKGROUND: DNA vaccines have emerged as an attractive approach for the generation of cytotoxic T lymphocytes (CTL). In our previous study, we found That Toll like receptor (TLR) ligands are promising candidates for the development of novel adjuvants for DNA vaccine. To improve the efficacy of DNA v...

Descripción completa

Detalles Bibliográficos
Autores principales: Gableh, Fateme, Saeidi, Mohsen, Hemati, Shaghayegh, Hamdi, Kasra, Soleimanjahi, Hoorieh, Gorji, Ali, Ghaemi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727273/
https://www.ncbi.nlm.nih.gov/pubmed/26811064
http://dx.doi.org/10.1186/s12929-016-0238-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727273/
https://www.ncbi.nlm.nih.gov/pubmed/26811064
http://dx.doi.org/10.1186/s12929-016-0238-3

Ejemplares similares